Phase 2 Kidney Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People (male or female) who have been diagnosed with breast cancer and have received treatment such as chemotherapy, radiotherapy, surgery, or other breast cancer treatments.
• People with a cancer other than breast cancer who received chemotherapy containing anthracyclines or platinum within the past 3 years.
• People with a cancer other than breast cancer who received other types of cancer treatment within the past 3 years.
• People aged 18 or older.
• People who feel, or whose doctor feels, that their memory or thinking abilities have gotten worse since their cancer diagnosis or since starting cancer treatment.
• People who are able to understand and agree to take part in the study (provide informed consent).
• People who can read and write in English, Chinese, Korean, Vietnamese, or Spanish, in order to complete the study questionnaires.
• People who are willing and able to complete questionnaires and computer-based assessments during the study. Note: People with vision problems or degenerative conditions (such as Parkinson's disease) may still be eligible if they can complete the questionnaires with assistance, even if they cannot complete the computer-based assessments (confirm with trial site).
• People currently taking part in another research study may still be considered eligible, if the principal investigator judges that the two studies would not interfere with each other scientifically or medically.

Who may not be able to join:

• People who have cancer that has spread to the brain (brain metastases).
• People who are not willing to undergo the thinking and memory assessments required by the study.
• Women who are currently pregnant, breastfeeding, or planning to become pregnant during the study period.
• Women who could potentially become pregnant must have a negative pregnancy test at the screening stage if there is any suspicion of pregnancy. Women considered not able to become pregnant must have a history of being postmenopausal for at least one year, or have had a tubal ligation or hysterectomy (confirm with trial site).
• People who have a known or suspected allergy to riluzole or any of its ingredients.
• People who are currently taking, or planning to take, certain medications or substances that could interact with the study drug — these include pixantrone, abametapir, cannabis, capmatinib, lapatinib, methotrexate, levoketoconazole, or people who have smoked within the last month.
• People with liver problems, specifically where certain liver enzyme levels (AST or ALT) are three or more times higher than the normal range.
• People with serious existing medical conditions that the investigator believes would make participation in the study unsafe or unsuitable.

Important: Always verify eligibility with the trial site directly before applying.